Live-attenuated LCMV-based vector for active immunotherapy of HPV16+ cancer.

Sarah Schmidt,Weldy V. Bonilla,Mindaugas Pauzuolis,Andrea Reiter,Theresa Kleissner,Daniel Oeler,Felix Stemeseder,Ursula Berka,Bettina Kiefmann,Sophie Schulha,Igor Matushansky,Doron Merkler,Daniel D. Pinschewer,Klaus Orlinger

Live-attenuated LCMV-based vector for active immunotherapy of HPV16+ cancer.

2019

Sarah Schmidt
Weldy V. Bonilla
Mindaugas Pauzuolis
Andrea Reiter
Theresa Kleissner
Daniel Oeler
Felix Stemeseder
Ursula Berka
Bettina Kiefmann
Sophie Schulha
Igor Matushansky
Doron Merkler
Daniel D. Pinschewer
Klaus Orlinger

e14303Background: Active immunization against cancer requires the induction of exquisitely potent tumor-specific CD8+ T cell (CTL) responses, which can be repeatedly boosted and reactivated. Hookip...

Keywords:

CTL*
CD8
Medicine
Immunology
Cancer
Active immunization
T cell
Active immunotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations